BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology, Thomas Jefferson University, Philadelphia, has been appointed chief of NCI's Radiation Research Program. She is former president of the American Radium Society and the American Cancer Society, Philadelphia Division.
BETHESDA, Md--Carol Mans-field, MD, professor of radiation oncology,Thomas Jefferson University, Philadelphia, has been appointedchief of NCI's Radiation Research Program. She is former presidentof the American Radium Society and the American Cancer Society,Philadelphia Division.
Kenneth Cowan, MD, head of the NCI Medicinal Breast Cancer Section,will serve as acting chief of the Medicine Branch, temporarilyreplacing Robert Wittes, MD, acting director of the Division ofCancer Treatment.
FDA Approves Imetelstat for Lower-Risk MDS With Transfusion-Dependent Anemia
June 7th 2024The FDA has approved imetelstat (Rytelo) for the treatment of adult patients with low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent anemia requiring at least 4 red blood cell units over 8 weeks who have not responded to, or have lost response to, or are ineligible for erythropoiesis-stimulating agents.